nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP1A1—Dacarbazine—melanoma	0.275	0.368	CbGbCtD
Granisetron—CYP3A4—Temozolomide—melanoma	0.153	0.205	CbGbCtD
Granisetron—CYP2D6—Vemurafenib—melanoma	0.132	0.177	CbGbCtD
Granisetron—CYP3A4—Vemurafenib—melanoma	0.0841	0.112	CbGbCtD
Granisetron—CYP3A5—Docetaxel—melanoma	0.074	0.0989	CbGbCtD
Granisetron—CYP3A4—Docetaxel—melanoma	0.0288	0.0386	CbGbCtD
Granisetron—Drug interaction—Docetaxel—melanoma	0.00134	0.00543	CcSEcCtD
Granisetron—Anaphylactic shock—Vemurafenib—melanoma	0.0013	0.00529	CcSEcCtD
Granisetron—Infection—Vemurafenib—melanoma	0.00129	0.00525	CcSEcCtD
Granisetron—Liver function test abnormal—Carmustine—melanoma	0.00129	0.00525	CcSEcCtD
Granisetron—Nervous system disorder—Vemurafenib—melanoma	0.00128	0.00519	CcSEcCtD
Granisetron—Hypokalaemia—Carmustine—melanoma	0.00127	0.00518	CcSEcCtD
Granisetron—Skin disorder—Vemurafenib—melanoma	0.00126	0.00514	CcSEcCtD
Granisetron—Hepatocellular injury—Docetaxel—melanoma	0.00124	0.00504	CcSEcCtD
Granisetron—Hypokalaemia—Temozolomide—melanoma	0.00123	0.005	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00122	0.00495	CcSEcCtD
Granisetron—Hypotension—Vemurafenib—melanoma	0.00122	0.00494	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Temozolomide—melanoma	0.00119	0.00485	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00119	0.00482	CcSEcCtD
Granisetron—Abdominal distension—Temozolomide—melanoma	0.00118	0.00478	CcSEcCtD
Granisetron—Fluid retention—Docetaxel—melanoma	0.00118	0.00478	CcSEcCtD
Granisetron—Decreased appetite—Vemurafenib—melanoma	0.00113	0.0046	CcSEcCtD
Granisetron—Gastrointestinal disorder—Vemurafenib—melanoma	0.00112	0.00457	CcSEcCtD
Granisetron—Constipation—Vemurafenib—melanoma	0.00111	0.00452	CcSEcCtD
Granisetron—Dysuria—Temozolomide—melanoma	0.00109	0.00444	CcSEcCtD
Granisetron—Photosensitivity reaction—Temozolomide—melanoma	0.00107	0.00434	CcSEcCtD
Granisetron—Urinary tract infection—Carmustine—melanoma	0.00105	0.00426	CcSEcCtD
Granisetron—Flushing—Bleomycin—melanoma	0.00103	0.00419	CcSEcCtD
Granisetron—Body temperature increased—Vemurafenib—melanoma	0.00103	0.00418	CcSEcCtD
Granisetron—Urinary tract infection—Temozolomide—melanoma	0.00101	0.00412	CcSEcCtD
Granisetron—Chills—Bleomycin—melanoma	0.000996	0.00405	CcSEcCtD
Granisetron—Hepatobiliary disease—Temozolomide—melanoma	0.000986	0.00401	CcSEcCtD
Granisetron—Alopecia—Bleomycin—melanoma	0.000981	0.00398	CcSEcCtD
Granisetron—Sinusitis—Temozolomide—melanoma	0.000979	0.00398	CcSEcCtD
Granisetron—Flushing—Dactinomycin—melanoma	0.000961	0.0039	CcSEcCtD
Granisetron—Hypersensitivity—Vemurafenib—melanoma	0.000959	0.0039	CcSEcCtD
Granisetron—Connective tissue disorder—Carmustine—melanoma	0.000952	0.00387	CcSEcCtD
Granisetron—Atrial fibrillation—Docetaxel—melanoma	0.00095	0.00386	CcSEcCtD
Granisetron—Asthenia—Vemurafenib—melanoma	0.000934	0.00379	CcSEcCtD
Granisetron—Visual impairment—Carmustine—melanoma	0.000934	0.00379	CcSEcCtD
Granisetron—Chills—Dactinomycin—melanoma	0.000929	0.00377	CcSEcCtD
Granisetron—Pruritus—Vemurafenib—melanoma	0.000921	0.00374	CcSEcCtD
Granisetron—Connective tissue disorder—Temozolomide—melanoma	0.00092	0.00374	CcSEcCtD
Granisetron—Alopecia—Dactinomycin—melanoma	0.000915	0.00372	CcSEcCtD
Granisetron—Hyponatraemia—Docetaxel—melanoma	0.000904	0.00367	CcSEcCtD
Granisetron—Visual impairment—Temozolomide—melanoma	0.000902	0.00367	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.0009	0.00366	CcSEcCtD
Granisetron—Flushing—Carmustine—melanoma	0.000899	0.00365	CcSEcCtD
Granisetron—Ill-defined disorder—Bleomycin—melanoma	0.000897	0.00364	CcSEcCtD
Granisetron—Anaemia—Bleomycin—melanoma	0.000893	0.00363	CcSEcCtD
Granisetron—Diarrhoea—Vemurafenib—melanoma	0.000891	0.00362	CcSEcCtD
Granisetron—Migraine—Docetaxel—melanoma	0.000886	0.0036	CcSEcCtD
Granisetron—Malaise—Bleomycin—melanoma	0.000871	0.00354	CcSEcCtD
Granisetron—Flushing—Temozolomide—melanoma	0.000869	0.00353	CcSEcCtD
Granisetron—Arrhythmia—Carmustine—melanoma	0.000866	0.00352	CcSEcCtD
Granisetron—Leukopenia—Bleomycin—melanoma	0.000865	0.00351	CcSEcCtD
Granisetron—Dizziness—Vemurafenib—melanoma	0.000861	0.0035	CcSEcCtD
Granisetron—Alopecia—Carmustine—melanoma	0.000856	0.00348	CcSEcCtD
Granisetron—Angiopathy—Temozolomide—melanoma	0.00085	0.00345	CcSEcCtD
Granisetron—Malnutrition—Carmustine—melanoma	0.000843	0.00343	CcSEcCtD
Granisetron—Cough—Bleomycin—melanoma	0.000843	0.00343	CcSEcCtD
Granisetron—Chills—Temozolomide—melanoma	0.00084	0.00341	CcSEcCtD
Granisetron—Ill-defined disorder—Dactinomycin—melanoma	0.000836	0.0034	CcSEcCtD
Granisetron—Anaemia—Dactinomycin—melanoma	0.000833	0.00338	CcSEcCtD
Granisetron—Liver function test abnormal—Docetaxel—melanoma	0.000831	0.00338	CcSEcCtD
Granisetron—Vomiting—Vemurafenib—melanoma	0.000828	0.00336	CcSEcCtD
Granisetron—Alopecia—Temozolomide—melanoma	0.000827	0.00336	CcSEcCtD
Granisetron—Chest pain—Bleomycin—melanoma	0.000823	0.00334	CcSEcCtD
Granisetron—Orthostatic hypotension—Docetaxel—melanoma	0.000822	0.00334	CcSEcCtD
Granisetron—Rash—Vemurafenib—melanoma	0.000821	0.00333	CcSEcCtD
Granisetron—Dermatitis—Vemurafenib—melanoma	0.00082	0.00333	CcSEcCtD
Granisetron—Headache—Vemurafenib—melanoma	0.000815	0.00331	CcSEcCtD
Granisetron—Malnutrition—Temozolomide—melanoma	0.000815	0.00331	CcSEcCtD
Granisetron—Discomfort—Bleomycin—melanoma	0.000813	0.0033	CcSEcCtD
Granisetron—Malaise—Dactinomycin—melanoma	0.000813	0.0033	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000811	0.00329	CcSEcCtD
Granisetron—Leukopenia—Dactinomycin—melanoma	0.000807	0.00328	CcSEcCtD
Granisetron—Dysgeusia—Temozolomide—melanoma	0.000798	0.00324	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Docetaxel—melanoma	0.000794	0.00323	CcSEcCtD
Granisetron—Tremor—Carmustine—melanoma	0.00079	0.00321	CcSEcCtD
Granisetron—Anaphylactic shock—Bleomycin—melanoma	0.000789	0.0032	CcSEcCtD
Granisetron—Oedema—Bleomycin—melanoma	0.000789	0.0032	CcSEcCtD
Granisetron—Infection—Bleomycin—melanoma	0.000783	0.00318	CcSEcCtD
Granisetron—Anaemia—Carmustine—melanoma	0.00078	0.00317	CcSEcCtD
Granisetron—Agitation—Carmustine—melanoma	0.000775	0.00315	CcSEcCtD
Granisetron—Nausea—Vemurafenib—melanoma	0.000773	0.00314	CcSEcCtD
Granisetron—Thrombocytopenia—Bleomycin—melanoma	0.000772	0.00314	CcSEcCtD
Granisetron—Tremor—Temozolomide—melanoma	0.000764	0.0031	CcSEcCtD
Granisetron—Discomfort—Dactinomycin—melanoma	0.000758	0.00308	CcSEcCtD
Granisetron—Angina pectoris—Docetaxel—melanoma	0.000758	0.00308	CcSEcCtD
Granisetron—Ill-defined disorder—Temozolomide—melanoma	0.000756	0.00307	CcSEcCtD
Granisetron—Leukopenia—Carmustine—melanoma	0.000755	0.00307	CcSEcCtD
Granisetron—Anaemia—Temozolomide—melanoma	0.000753	0.00306	CcSEcCtD
Granisetron—Agitation—Temozolomide—melanoma	0.000749	0.00304	CcSEcCtD
Granisetron—Hypotension—Bleomycin—melanoma	0.000737	0.00299	CcSEcCtD
Granisetron—Oedema—Dactinomycin—melanoma	0.000735	0.00299	CcSEcCtD
Granisetron—Malaise—Temozolomide—melanoma	0.000735	0.00299	CcSEcCtD
Granisetron—Vertigo—Temozolomide—melanoma	0.000732	0.00298	CcSEcCtD
Granisetron—Infection—Dactinomycin—melanoma	0.000731	0.00297	CcSEcCtD
Granisetron—Leukopenia—Temozolomide—melanoma	0.00073	0.00296	CcSEcCtD
Granisetron—Hypertension—Carmustine—melanoma	0.000728	0.00296	CcSEcCtD
Granisetron—Palpitations—Temozolomide—melanoma	0.00072	0.00293	CcSEcCtD
Granisetron—Thrombocytopenia—Dactinomycin—melanoma	0.00072	0.00293	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Bleomycin—melanoma	0.000718	0.00292	CcSEcCtD
Granisetron—Chest pain—Carmustine—melanoma	0.000718	0.00292	CcSEcCtD
Granisetron—Anxiety—Carmustine—melanoma	0.000716	0.00291	CcSEcCtD
Granisetron—Cough—Temozolomide—melanoma	0.000711	0.00289	CcSEcCtD
Granisetron—Paraesthesia—Bleomycin—melanoma	0.000708	0.00288	CcSEcCtD
Granisetron—Hypertension—Temozolomide—melanoma	0.000704	0.00286	CcSEcCtD
Granisetron—Dyspnoea—Bleomycin—melanoma	0.000703	0.00286	CcSEcCtD
Granisetron—Arthralgia—Temozolomide—melanoma	0.000694	0.00282	CcSEcCtD
Granisetron—Anxiety—Temozolomide—melanoma	0.000692	0.00281	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000689	0.0028	CcSEcCtD
Granisetron—Oedema—Carmustine—melanoma	0.000688	0.0028	CcSEcCtD
Granisetron—Discomfort—Temozolomide—melanoma	0.000686	0.00279	CcSEcCtD
Granisetron—Decreased appetite—Bleomycin—melanoma	0.000686	0.00279	CcSEcCtD
Granisetron—Infection—Carmustine—melanoma	0.000684	0.00278	CcSEcCtD
Granisetron—Dry mouth—Temozolomide—melanoma	0.000679	0.00276	CcSEcCtD
Granisetron—Jaundice—Docetaxel—melanoma	0.000676	0.00275	CcSEcCtD
Granisetron—Pain—Bleomycin—melanoma	0.000674	0.00274	CcSEcCtD
Granisetron—Thrombocytopenia—Carmustine—melanoma	0.000674	0.00274	CcSEcCtD
Granisetron—Tachycardia—Carmustine—melanoma	0.000672	0.00273	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00067	0.00272	CcSEcCtD
Granisetron—Oedema—Temozolomide—melanoma	0.000665	0.0027	CcSEcCtD
Granisetron—Anaphylactic shock—Temozolomide—melanoma	0.000665	0.0027	CcSEcCtD
Granisetron—Infection—Temozolomide—melanoma	0.000661	0.00268	CcSEcCtD
Granisetron—Hepatobiliary disease—Docetaxel—melanoma	0.000656	0.00267	CcSEcCtD
Granisetron—Epistaxis—Docetaxel—melanoma	0.000654	0.00266	CcSEcCtD
Granisetron—Nervous system disorder—Temozolomide—melanoma	0.000652	0.00265	CcSEcCtD
Granisetron—Thrombocytopenia—Temozolomide—melanoma	0.000651	0.00265	CcSEcCtD
Granisetron—Feeling abnormal—Bleomycin—melanoma	0.00065	0.00264	CcSEcCtD
Granisetron—Skin disorder—Temozolomide—melanoma	0.000646	0.00263	CcSEcCtD
Granisetron—Hypotension—Carmustine—melanoma	0.000643	0.00261	CcSEcCtD
Granisetron—Hyperhidrosis—Temozolomide—melanoma	0.000643	0.00261	CcSEcCtD
Granisetron—Decreased appetite—Dactinomycin—melanoma	0.000639	0.0026	CcSEcCtD
Granisetron—Pain—Dactinomycin—melanoma	0.000629	0.00256	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Carmustine—melanoma	0.000627	0.00255	CcSEcCtD
Granisetron—Urticaria—Bleomycin—melanoma	0.000626	0.00255	CcSEcCtD
Granisetron—Rhinitis—Docetaxel—melanoma	0.000624	0.00254	CcSEcCtD
Granisetron—Body temperature increased—Bleomycin—melanoma	0.000623	0.00253	CcSEcCtD
Granisetron—Insomnia—Carmustine—melanoma	0.000623	0.00253	CcSEcCtD
Granisetron—Paraesthesia—Carmustine—melanoma	0.000618	0.00251	CcSEcCtD
Granisetron—Dyspnoea—Carmustine—melanoma	0.000614	0.00249	CcSEcCtD
Granisetron—Somnolence—Carmustine—melanoma	0.000612	0.00249	CcSEcCtD
Granisetron—Connective tissue disorder—Docetaxel—melanoma	0.000612	0.00249	CcSEcCtD
Granisetron—Feeling abnormal—Dactinomycin—melanoma	0.000606	0.00246	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Temozolomide—melanoma	0.000606	0.00246	CcSEcCtD
Granisetron—Insomnia—Temozolomide—melanoma	0.000602	0.00244	CcSEcCtD
Granisetron—Gastrointestinal pain—Dactinomycin—melanoma	0.000601	0.00244	CcSEcCtD
Granisetron—Visual impairment—Docetaxel—melanoma	0.0006	0.00244	CcSEcCtD
Granisetron—Decreased appetite—Carmustine—melanoma	0.000598	0.00243	CcSEcCtD
Granisetron—Paraesthesia—Temozolomide—melanoma	0.000597	0.00243	CcSEcCtD
Granisetron—Gastrointestinal disorder—Carmustine—melanoma	0.000594	0.00241	CcSEcCtD
Granisetron—Dyspnoea—Temozolomide—melanoma	0.000593	0.00241	CcSEcCtD
Granisetron—Somnolence—Temozolomide—melanoma	0.000591	0.0024	CcSEcCtD
Granisetron—Constipation—Carmustine—melanoma	0.000589	0.00239	CcSEcCtD
Granisetron—Pain—Carmustine—melanoma	0.000589	0.00239	CcSEcCtD
Granisetron—Dyspepsia—Temozolomide—melanoma	0.000586	0.00238	CcSEcCtD
Granisetron—Abdominal pain—Dactinomycin—melanoma	0.000581	0.00236	CcSEcCtD
Granisetron—Body temperature increased—Dactinomycin—melanoma	0.000581	0.00236	CcSEcCtD
Granisetron—Hypersensitivity—Bleomycin—melanoma	0.000581	0.00236	CcSEcCtD
Granisetron—Decreased appetite—Temozolomide—melanoma	0.000578	0.00235	CcSEcCtD
Granisetron—Flushing—Docetaxel—melanoma	0.000578	0.00235	CcSEcCtD
Granisetron—Gastrointestinal disorder—Temozolomide—melanoma	0.000574	0.00233	CcSEcCtD
Granisetron—Pain—Temozolomide—melanoma	0.000569	0.00231	CcSEcCtD
Granisetron—Constipation—Temozolomide—melanoma	0.000569	0.00231	CcSEcCtD
Granisetron—Feeling abnormal—Carmustine—melanoma	0.000567	0.0023	CcSEcCtD
Granisetron—Asthenia—Bleomycin—melanoma	0.000566	0.0023	CcSEcCtD
Granisetron—Angiopathy—Docetaxel—melanoma	0.000565	0.0023	CcSEcCtD
Granisetron—Gastrointestinal pain—Carmustine—melanoma	0.000563	0.00229	CcSEcCtD
Granisetron—Chills—Docetaxel—melanoma	0.000559	0.00227	CcSEcCtD
Granisetron—Pruritus—Bleomycin—melanoma	0.000558	0.00227	CcSEcCtD
Granisetron—Arrhythmia—Docetaxel—melanoma	0.000556	0.00226	CcSEcCtD
Granisetron—Alopecia—Docetaxel—melanoma	0.00055	0.00224	CcSEcCtD
Granisetron—Feeling abnormal—Temozolomide—melanoma	0.000548	0.00223	CcSEcCtD
Granisetron—Abdominal pain—Carmustine—melanoma	0.000544	0.00221	CcSEcCtD
Granisetron—Body temperature increased—Carmustine—melanoma	0.000544	0.00221	CcSEcCtD
Granisetron—Gastrointestinal pain—Temozolomide—melanoma	0.000544	0.00221	CcSEcCtD
Granisetron—Malnutrition—Docetaxel—melanoma	0.000542	0.0022	CcSEcCtD
Granisetron—Hypersensitivity—Dactinomycin—melanoma	0.000542	0.0022	CcSEcCtD
Granisetron—Dysgeusia—Docetaxel—melanoma	0.000531	0.00216	CcSEcCtD
Granisetron—Urticaria—Temozolomide—melanoma	0.000528	0.00215	CcSEcCtD
Granisetron—Asthenia—Dactinomycin—melanoma	0.000528	0.00214	CcSEcCtD
Granisetron—Abdominal pain—Temozolomide—melanoma	0.000526	0.00214	CcSEcCtD
Granisetron—Body temperature increased—Temozolomide—melanoma	0.000526	0.00214	CcSEcCtD
Granisetron—Hypersensitivity—Carmustine—melanoma	0.000507	0.00206	CcSEcCtD
Granisetron—Diarrhoea—Dactinomycin—melanoma	0.000503	0.00204	CcSEcCtD
Granisetron—Vomiting—Bleomycin—melanoma	0.000501	0.00204	CcSEcCtD
Granisetron—Anaemia—Docetaxel—melanoma	0.000501	0.00204	CcSEcCtD
Granisetron—Rash—Bleomycin—melanoma	0.000497	0.00202	CcSEcCtD
Granisetron—Dermatitis—Bleomycin—melanoma	0.000497	0.00202	CcSEcCtD
Granisetron—Asthenia—Carmustine—melanoma	0.000494	0.00201	CcSEcCtD
Granisetron—Hypersensitivity—Temozolomide—melanoma	0.00049	0.00199	CcSEcCtD
Granisetron—Syncope—Docetaxel—melanoma	0.000486	0.00197	CcSEcCtD
Granisetron—Leukopenia—Docetaxel—melanoma	0.000485	0.00197	CcSEcCtD
Granisetron—Palpitations—Docetaxel—melanoma	0.000479	0.00195	CcSEcCtD
Granisetron—Asthenia—Temozolomide—melanoma	0.000477	0.00194	CcSEcCtD
Granisetron—Loss of consciousness—Docetaxel—melanoma	0.000476	0.00194	CcSEcCtD
Granisetron—Cough—Docetaxel—melanoma	0.000473	0.00192	CcSEcCtD
Granisetron—Diarrhoea—Carmustine—melanoma	0.000471	0.00191	CcSEcCtD
Granisetron—Pruritus—Temozolomide—melanoma	0.000471	0.00191	CcSEcCtD
Granisetron—Nausea—Bleomycin—melanoma	0.000468	0.0019	CcSEcCtD
Granisetron—Hypertension—Docetaxel—melanoma	0.000468	0.0019	CcSEcCtD
Granisetron—Vomiting—Dactinomycin—melanoma	0.000468	0.0019	CcSEcCtD
Granisetron—Rash—Dactinomycin—melanoma	0.000464	0.00188	CcSEcCtD
Granisetron—Arthralgia—Docetaxel—melanoma	0.000461	0.00187	CcSEcCtD
Granisetron—Chest pain—Docetaxel—melanoma	0.000461	0.00187	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000458	0.00186	CcSEcCtD
Granisetron—Dizziness—Carmustine—melanoma	0.000455	0.00185	CcSEcCtD
Granisetron—Diarrhoea—Temozolomide—melanoma	0.000455	0.00185	CcSEcCtD
Granisetron—Dry mouth—Docetaxel—melanoma	0.000451	0.00183	CcSEcCtD
Granisetron—Anaphylactic shock—Docetaxel—melanoma	0.000442	0.0018	CcSEcCtD
Granisetron—Oedema—Docetaxel—melanoma	0.000442	0.0018	CcSEcCtD
Granisetron—Dizziness—Temozolomide—melanoma	0.00044	0.00179	CcSEcCtD
Granisetron—Infection—Docetaxel—melanoma	0.000439	0.00179	CcSEcCtD
Granisetron—Vomiting—Carmustine—melanoma	0.000438	0.00178	CcSEcCtD
Granisetron—Nausea—Dactinomycin—melanoma	0.000437	0.00177	CcSEcCtD
Granisetron—Shock—Docetaxel—melanoma	0.000435	0.00177	CcSEcCtD
Granisetron—Rash—Carmustine—melanoma	0.000434	0.00176	CcSEcCtD
Granisetron—Nervous system disorder—Docetaxel—melanoma	0.000434	0.00176	CcSEcCtD
Granisetron—Dermatitis—Carmustine—melanoma	0.000434	0.00176	CcSEcCtD
Granisetron—Thrombocytopenia—Docetaxel—melanoma	0.000433	0.00176	CcSEcCtD
Granisetron—Tachycardia—Docetaxel—melanoma	0.000432	0.00175	CcSEcCtD
Granisetron—Headache—Carmustine—melanoma	0.000431	0.00175	CcSEcCtD
Granisetron—Skin disorder—Docetaxel—melanoma	0.00043	0.00175	CcSEcCtD
Granisetron—Vomiting—Temozolomide—melanoma	0.000423	0.00172	CcSEcCtD
Granisetron—Rash—Temozolomide—melanoma	0.000419	0.0017	CcSEcCtD
Granisetron—Dermatitis—Temozolomide—melanoma	0.000419	0.0017	CcSEcCtD
Granisetron—Headache—Temozolomide—melanoma	0.000417	0.00169	CcSEcCtD
Granisetron—Hypotension—Docetaxel—melanoma	0.000413	0.00168	CcSEcCtD
Granisetron—Nausea—Carmustine—melanoma	0.000409	0.00166	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Docetaxel—melanoma	0.000403	0.00164	CcSEcCtD
Granisetron—Insomnia—Docetaxel—melanoma	0.0004	0.00163	CcSEcCtD
Granisetron—Paraesthesia—Docetaxel—melanoma	0.000397	0.00161	CcSEcCtD
Granisetron—Nausea—Temozolomide—melanoma	0.000395	0.00161	CcSEcCtD
Granisetron—Dyspnoea—Docetaxel—melanoma	0.000394	0.0016	CcSEcCtD
Granisetron—Somnolence—Docetaxel—melanoma	0.000393	0.0016	CcSEcCtD
Granisetron—Dyspepsia—Docetaxel—melanoma	0.000389	0.00158	CcSEcCtD
Granisetron—Decreased appetite—Docetaxel—melanoma	0.000385	0.00156	CcSEcCtD
Granisetron—Gastrointestinal disorder—Docetaxel—melanoma	0.000382	0.00155	CcSEcCtD
Granisetron—Pain—Docetaxel—melanoma	0.000378	0.00154	CcSEcCtD
Granisetron—Constipation—Docetaxel—melanoma	0.000378	0.00154	CcSEcCtD
Granisetron—Feeling abnormal—Docetaxel—melanoma	0.000365	0.00148	CcSEcCtD
Granisetron—Gastrointestinal pain—Docetaxel—melanoma	0.000362	0.00147	CcSEcCtD
Granisetron—Body temperature increased—Docetaxel—melanoma	0.00035	0.00142	CcSEcCtD
Granisetron—Abdominal pain—Docetaxel—melanoma	0.00035	0.00142	CcSEcCtD
Granisetron—Hypersensitivity—Docetaxel—melanoma	0.000326	0.00132	CcSEcCtD
Granisetron—Asthenia—Docetaxel—melanoma	0.000317	0.00129	CcSEcCtD
Granisetron—Pruritus—Docetaxel—melanoma	0.000313	0.00127	CcSEcCtD
Granisetron—Diarrhoea—Docetaxel—melanoma	0.000303	0.00123	CcSEcCtD
Granisetron—Dizziness—Docetaxel—melanoma	0.000293	0.00119	CcSEcCtD
Granisetron—Vomiting—Docetaxel—melanoma	0.000281	0.00114	CcSEcCtD
Granisetron—Rash—Docetaxel—melanoma	0.000279	0.00113	CcSEcCtD
Granisetron—Dermatitis—Docetaxel—melanoma	0.000279	0.00113	CcSEcCtD
Granisetron—Headache—Docetaxel—melanoma	0.000277	0.00113	CcSEcCtD
Granisetron—Nausea—Docetaxel—melanoma	0.000263	0.00107	CcSEcCtD
Granisetron—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	3.61e-05	0.00595	CbGpPWpGaD
Granisetron—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—melanoma	3.56e-05	0.00587	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—AKR1B10—melanoma	3.52e-05	0.0058	CbGpPWpGaD
Granisetron—CYP2D6—Melatonin metabolism and effects—PRKCA—melanoma	3.48e-05	0.00573	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	3.48e-05	0.00573	CbGpPWpGaD
Granisetron—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	3.41e-05	0.00562	CbGpPWpGaD
Granisetron—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—melanoma	3.37e-05	0.00555	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—AKR1B10—melanoma	3.33e-05	0.00548	CbGpPWpGaD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	3.29e-05	0.00541	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—E2F1—melanoma	3.26e-05	0.00538	CbGpPWpGaD
Granisetron—CYP3A4—Irinotecan Pathway—APC—melanoma	3.19e-05	0.00526	CbGpPWpGaD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	3.05e-05	0.00502	CbGpPWpGaD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—melanoma	3.01e-05	0.00496	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	2.93e-05	0.00482	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—CDK2—melanoma	2.82e-05	0.00464	CbGpPWpGaD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	2.77e-05	0.00456	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—GPAM—melanoma	2.61e-05	0.0043	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—UGT2B10—melanoma	2.58e-05	0.00425	CbGpPWpGaD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	2.57e-05	0.00423	CbGpPWpGaD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—melanoma	2.53e-05	0.00417	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—AKR1B10—melanoma	2.51e-05	0.00413	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	2.47e-05	0.00407	CbGpPWpGaD
Granisetron—CYP1A1—Melatonin metabolism and effects—NFKB1—melanoma	2.39e-05	0.00393	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—CXCL8—melanoma	2.35e-05	0.00387	CbGpPWpGaD
Granisetron—CYP1A1—Oxidative Stress—NFKB1—melanoma	2.32e-05	0.00383	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—RB1—melanoma	2.31e-05	0.00381	CbGpPWpGaD
Granisetron—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	2.29e-05	0.00377	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—CASP3—melanoma	2.25e-05	0.0037	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—MAP2K1—melanoma	2.22e-05	0.00365	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—ACER3—melanoma	2.2e-05	0.00362	CbGpPWpGaD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	2.18e-05	0.00359	CbGpPWpGaD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	2.17e-05	0.00358	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—CTNNB1—melanoma	2.16e-05	0.00357	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—NFKB1—melanoma	2.1e-05	0.00346	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	2.08e-05	0.00343	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	2.08e-05	0.00342	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	1.99e-05	0.00329	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	1.98e-05	0.00327	CbGpPWpGaD
Granisetron—CYP1A1—Tryptophan metabolism—MDM2—melanoma	1.97e-05	0.00325	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	1.97e-05	0.00324	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—SLC5A5—melanoma	1.96e-05	0.00323	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—melanoma	1.91e-05	0.00314	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—melanoma	1.9e-05	0.00313	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP17A1—melanoma	1.85e-05	0.00304	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP17A1—melanoma	1.82e-05	0.003	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—melanoma	1.8e-05	0.00297	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	1.8e-05	0.00297	CbGpPWpGaD
Granisetron—CYP2D6—Melatonin metabolism and effects—NFKB1—melanoma	1.8e-05	0.00296	CbGpPWpGaD
Granisetron—CYP1A1—Arachidonic acid metabolism—PTGS2—melanoma	1.78e-05	0.00293	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	1.76e-05	0.0029	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP17A1—melanoma	1.75e-05	0.00287	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP17A1—melanoma	1.72e-05	0.00284	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	1.68e-05	0.00277	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—melanoma	1.66e-05	0.00274	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	1.66e-05	0.00273	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—melanoma	1.65e-05	0.00272	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	1.64e-05	0.0027	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—TNF—melanoma	1.63e-05	0.00269	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	1.62e-05	0.00266	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—melanoma	1.56e-05	0.00256	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP1B1—melanoma	1.55e-05	0.00256	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP1B1—melanoma	1.53e-05	0.00253	CbGpPWpGaD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	1.51e-05	0.0025	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—melanoma	1.5e-05	0.00247	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—ABCB1—melanoma	1.49e-05	0.00246	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—melanoma	1.48e-05	0.00244	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP1B1—melanoma	1.47e-05	0.00242	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP1B1—melanoma	1.45e-05	0.00239	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—MYC—melanoma	1.38e-05	0.00227	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	1.36e-05	0.00224	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—melanoma	1.35e-05	0.00222	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—melanoma	1.35e-05	0.00222	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	1.35e-05	0.00222	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	1.33e-05	0.00219	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—IL6—melanoma	1.32e-05	0.00217	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP17A1—melanoma	1.31e-05	0.00216	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	1.3e-05	0.00213	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	1.28e-05	0.00211	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—TNF—melanoma	1.28e-05	0.00211	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—melanoma	1.27e-05	0.0021	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—PPARG—melanoma	1.2e-05	0.00198	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—melanoma	1.18e-05	0.00194	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CUBN—melanoma	1.11e-05	0.00183	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP1B1—melanoma	1.11e-05	0.00182	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	1.09e-05	0.0018	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—melanoma	1.08e-05	0.00178	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—GPAM—melanoma	1.04e-05	0.00171	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ACER3—melanoma	1.04e-05	0.00171	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ACER3—melanoma	9.79e-06	0.00161	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—MDM2—melanoma	9.71e-06	0.0016	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—UGT2B10—melanoma	9.48e-06	0.00156	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—ALB—melanoma	9.34e-06	0.00154	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—UGT2B10—melanoma	8.96e-06	0.00148	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	8.84e-06	0.00146	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HS3ST5—melanoma	8.81e-06	0.00145	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP17A1—melanoma	8.59e-06	0.00141	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	8.47e-06	0.0014	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HS3ST5—melanoma	8.33e-06	0.00137	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—melanoma	8.12e-06	0.00134	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ACER3—melanoma	7.37e-06	0.00121	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP1B1—melanoma	7.23e-06	0.00119	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	7.13e-06	0.00117	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—UGT2B10—melanoma	6.74e-06	0.00111	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	6.7e-06	0.0011	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PLCB4—melanoma	6.68e-06	0.0011	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PLCB4—melanoma	6.31e-06	0.00104	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIP4K2A—melanoma	6.28e-06	0.00103	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SLC6A11—melanoma	6.28e-06	0.00103	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HS3ST5—melanoma	6.27e-06	0.00103	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—FASN—melanoma	6.19e-06	0.00102	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—MTAP—melanoma	6.11e-06	0.00101	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIP4K2A—melanoma	5.93e-06	0.000977	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC6A11—melanoma	5.93e-06	0.000977	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—MTAP—melanoma	5.77e-06	0.000951	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	5.64e-06	0.000929	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PHGDH—melanoma	5.44e-06	0.000897	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—LUM—melanoma	5.44e-06	0.000897	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HPSE—melanoma	5.34e-06	0.00088	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CUBN—melanoma	5.24e-06	0.000863	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—LUM—melanoma	5.14e-06	0.000847	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PHGDH—melanoma	5.14e-06	0.000847	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SDHD—melanoma	5.06e-06	0.000834	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CSPG4—melanoma	5.06e-06	0.000834	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—BSG—melanoma	5.06e-06	0.000834	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HPSE—melanoma	5.04e-06	0.000831	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CUBN—melanoma	4.95e-06	0.000816	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GPAM—melanoma	4.9e-06	0.000808	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ACER3—melanoma	4.82e-06	0.000794	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SDHD—melanoma	4.78e-06	0.000788	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—BSG—melanoma	4.78e-06	0.000788	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CSPG4—melanoma	4.78e-06	0.000788	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PLCB4—melanoma	4.75e-06	0.000782	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GPAM—melanoma	4.63e-06	0.000763	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC6A11—melanoma	4.47e-06	0.000736	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIP4K2A—melanoma	4.47e-06	0.000736	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—UGT2B10—melanoma	4.41e-06	0.000726	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—MTAP—melanoma	4.34e-06	0.000716	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PLA2G6—melanoma	4.17e-06	0.000687	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HS3ST5—melanoma	4.1e-06	0.000675	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PLA2G6—melanoma	3.94e-06	0.000649	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PHGDH—melanoma	3.87e-06	0.000638	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—LUM—melanoma	3.87e-06	0.000638	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HPSE—melanoma	3.8e-06	0.000625	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—VCAN—melanoma	3.74e-06	0.000617	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CUBN—melanoma	3.73e-06	0.000614	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SDHD—melanoma	3.6e-06	0.000593	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CSPG4—melanoma	3.6e-06	0.000593	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—BSG—melanoma	3.6e-06	0.000593	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—VCAN—melanoma	3.54e-06	0.000583	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GPAM—melanoma	3.49e-06	0.000574	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.35e-06	0.000552	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.23e-06	0.000532	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP17A1—melanoma	3.16e-06	0.00052	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PLCB4—melanoma	3.11e-06	0.000512	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP17A1—melanoma	2.98e-06	0.000492	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GNA11—melanoma	2.98e-06	0.000491	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PLA2G6—melanoma	2.96e-06	0.000488	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.94e-06	0.000485	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC6A11—melanoma	2.92e-06	0.000481	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIP4K2A—melanoma	2.92e-06	0.000481	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—FASN—melanoma	2.92e-06	0.000481	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.91e-06	0.000479	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SLC5A5—melanoma	2.87e-06	0.000473	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—MTAP—melanoma	2.84e-06	0.000468	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GNA11—melanoma	2.82e-06	0.000464	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GNAQ—melanoma	2.77e-06	0.000457	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CD44—melanoma	2.77e-06	0.000457	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—FASN—melanoma	2.76e-06	0.000454	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC5A5—melanoma	2.71e-06	0.000447	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—VCAN—melanoma	2.66e-06	0.000439	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP1B1—melanoma	2.66e-06	0.000438	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GNAQ—melanoma	2.62e-06	0.000432	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CD44—melanoma	2.62e-06	0.000432	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.57e-06	0.000423	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.54e-06	0.000419	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PHGDH—melanoma	2.53e-06	0.000417	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—LUM—melanoma	2.53e-06	0.000417	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP1B1—melanoma	2.51e-06	0.000414	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HPSE—melanoma	2.48e-06	0.000409	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CUBN—melanoma	2.44e-06	0.000401	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SDHD—melanoma	2.35e-06	0.000388	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—BSG—melanoma	2.35e-06	0.000388	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CSPG4—melanoma	2.35e-06	0.000388	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GPAM—melanoma	2.28e-06	0.000375	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP17A1—melanoma	2.25e-06	0.00037	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.22e-06	0.000365	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ABCB1—melanoma	2.19e-06	0.000361	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GNA11—melanoma	2.12e-06	0.000349	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—FASN—melanoma	2.08e-06	0.000342	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ABCB1—melanoma	2.07e-06	0.000341	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC5A5—melanoma	2.04e-06	0.000336	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PRKCA—melanoma	2.02e-06	0.000332	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ERCC2—melanoma	2e-06	0.000329	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GNAQ—melanoma	1.97e-06	0.000325	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CD44—melanoma	1.97e-06	0.000325	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PLA2G6—melanoma	1.94e-06	0.000319	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PRKCA—melanoma	1.9e-06	0.000314	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP1B1—melanoma	1.89e-06	0.000311	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ERCC2—melanoma	1.89e-06	0.000311	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—VCAN—melanoma	1.74e-06	0.000287	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CG—melanoma	1.58e-06	0.00026	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.56e-06	0.000258	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ABCB1—melanoma	1.56e-06	0.000256	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PPARG—melanoma	1.52e-06	0.000251	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CG—melanoma	1.49e-06	0.000246	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP17A1—melanoma	1.47e-06	0.000242	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PPARG—melanoma	1.44e-06	0.000237	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PRKCA—melanoma	1.43e-06	0.000236	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ERCC2—melanoma	1.42e-06	0.000234	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CD—melanoma	1.39e-06	0.000229	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GNA11—melanoma	1.39e-06	0.000228	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALB—melanoma	1.37e-06	0.000226	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—FASN—melanoma	1.36e-06	0.000224	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC5A5—melanoma	1.34e-06	0.00022	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CD—melanoma	1.31e-06	0.000216	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALB—melanoma	1.29e-06	0.000213	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GNAQ—melanoma	1.29e-06	0.000212	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CD44—melanoma	1.29e-06	0.000212	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP1B1—melanoma	1.24e-06	0.000204	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CB—melanoma	1.21e-06	0.000199	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTGS2—melanoma	1.2e-06	0.000197	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CB—melanoma	1.14e-06	0.000188	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTGS2—melanoma	1.13e-06	0.000187	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CG—melanoma	1.12e-06	0.000185	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PPARG—melanoma	1.08e-06	0.000178	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTEN—melanoma	1.05e-06	0.000172	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ABCB1—melanoma	1.02e-06	0.000168	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTEN—melanoma	9.87e-07	0.000163	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CD—melanoma	9.87e-07	0.000163	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALB—melanoma	9.74e-07	0.00016	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PRKCA—melanoma	9.37e-07	0.000154	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ERCC2—melanoma	9.29e-07	0.000153	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CB—melanoma	8.6e-07	0.000142	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTGS2—melanoma	8.52e-07	0.00014	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTEN—melanoma	7.43e-07	0.000122	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CA—melanoma	7.37e-07	0.000121	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CG—melanoma	7.34e-07	0.000121	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PPARG—melanoma	7.08e-07	0.000117	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CA—melanoma	6.97e-07	0.000115	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CD—melanoma	6.45e-07	0.000106	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALB—melanoma	6.37e-07	0.000105	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—AKT1—melanoma	6.02e-07	9.92e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—AKT1—melanoma	5.69e-07	9.37e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CB—melanoma	5.62e-07	9.26e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTGS2—melanoma	5.57e-07	9.18e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CA—melanoma	5.24e-07	8.64e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTEN—melanoma	4.86e-07	8e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—AKT1—melanoma	4.28e-07	7.06e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CA—melanoma	3.43e-07	5.65e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—AKT1—melanoma	2.8e-07	4.61e-05	CbGpPWpGaD
